First Trust Advisors
RIGL icon

First Trust Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

First Trust Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Buy
81,342
+14,673
+22% +$453K ﹤0.01% 1807
2026
Q1 		$1.8M Buy
66,669
+1,844
+3% +$62K ﹤0.01% 1968
2025
Q4 		$2.78M Buy
64,825
+7,204
+13% +$272K ﹤0.01% 1732
2025
Q3 		$1.63M Buy
+57,621
New +$1.72M ﹤0.01% 1924

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors's RIGL Position: Q2 2026 in Review

First Trust Advisors increased its Rigel Pharmaceuticals (RIGL) stake by 22% in Q2 2026, buying an estimated $453K and bringing the position to 81,342 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

First Trust Advisors first reported a position in RIGL in Q3 2025 and has held it in 4 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • First Trust Advisors held 81,342 shares of Rigel Pharmaceuticals worth $3.18M as of Q2 2026.
  • First Trust Advisors bought 14,673 Rigel Pharmaceuticals shares in Q2 2026, an estimated $453K.
  • Rigel Pharmaceuticals made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1807 holding.
  • First Trust Advisors first reported a position in Rigel Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.